🔍
Search Results - wuu-jyh+lin
2
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Synthesis of High Affinity Liver-Targeting Reagent based on Multivalency Effect of Sugar Binding
Value Proposition· Non-invasive imaging agent correlates with liver function and can detect low levels of liver-fibrosis.· Imaging agent has higher sensitivity than traditional liver function tests.· Glyco-ligand can potentially be used to target other drugs to the liver. Technology DescriptionCurrent methods for detecting liver...
Published: 3/13/2025
|
Inventor(s):
Mei-Hui Wang
,
Reiko Lee
,
Wuu-Jyh Lin
,
Yuan Lee
Keywords(s):
Disease Indication
,
Liver Disorders
,
Novel
,
Predicted Novelty
,
Single
,
Small Molecules
,
Targeted Therapy
,
Therapeutic Matter
,
Therapeutic Substance
,
Therapeutics
,
Therapy Type
Category(s):
Clinical and Disease Specializations > Hepatology
,
Technology Classifications > Therapeutic Modalities
,
Clinical and Disease Specializations > Hepatology > Acute Liver Failure
,
Technology Classifications > Diagnostics > In Vivo Diagnostics
,
Clinical and Disease Specializations > Hepatology > Liver Fibrosis
,
Technology Classifications > Diagnostics > Diagnostic Imaging
A p105-based NF-(kappa) B Super repressor
C04290: A p105-based NF-(kappa) B Super repressor Technical Details: Nuclear factor (NF)-kB is a family of transcription factors that regulate immune and inflammatory responses, programmed cell death (apoptosis), and developmental processes. In normal cells, NF-kB is latent, and is activated transiently by stimuli and stresses. However, under pathological...
Published: 3/13/2025
|
Inventor(s):
Li Lin
Keywords(s):
Biologics
,
Cancers
,
Chemotherapy
,
Disease Indication
,
Nucleic Acid
,
Single
,
Skin Cancer
,
Therapeutic Matter
,
Therapeutic Substance
,
Therapeutics
,
Therapy Type
Category(s):
Clinical and Disease Specializations
,
Clinical and Disease Specializations > Dermatology
,
Clinical and Disease Specializations > Oncology > Skin Cancer
,
Technology Classifications > Therapeutic Modalities > Gene Therapies
,
Technology Classifications > Therapeutic Modalities > Proteins
,
Technology Classifications > Therapeutic Modalities > Targets
,
Clinical and Disease Specializations > Oncology
,
Technology Classifications > Therapeutic Modalities
JHTV Home
|
Search
|
Login/Subscribe
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by
Inteum